Minimal Inhibitory Concentrations of Rifabutin, Ciprofloxacin, and Ofloxacin againstMycobacterium tuberculosisIsolated before Treatment of Patients in Taiwan
- 1 October 1989
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 140 (4) , 987-989
- https://doi.org/10.1164/ajrccm/140.4.987
Abstract
Minimal inhibitory concentrations (MICs) of rifabutin, ciprofloxacin, and ofloxacin were determined for "wild" Mycobacterium tuberculosis strains, susceptible to all antituberculosis drugs in the conventional test, isolated from newly diagnosed Taiwanese patients who had never had prior treatment for tuberculosis. These MICs were within the limits previously reported for strains isolated in the United States. The range of MICs of rifabutin for Taiwanese strains was 0.015 to 0.125 .mu.g/ml; ciprofloxacin, 0.25 to 2.0 .mu.g/ml; ofloxacin, 0.5 to 2.0 .mu.g/ml. On the basis of an evaluation of the highest broth-determined MICs found in this and in a previous study, we suggest that the following MICs, when determined in 7H12 broth radiometrically, should be used as breakpoints to classify the strain as "susceptible": for rifabutin, 0.125 .mu.g/ml or less; for ofloxacin and ciprofloxain, 2.0 .mu.g/ml or less.This publication has 18 references indexed in Scilit:
- Qualitative and Quantitative Drug-susceptibility Tests in MycobacteriologyAmerican Review of Respiratory Disease, 1988
- In-vitro activity of fleroxacin (Ro 23-6240), a new fluoro-qoinolone, and other agents, against Mycobacterium spp.Journal of Antimicrobial Chemotherapy, 1988
- Rifabutine: Minimal Inhibitory and Bactericidal Concentrations forMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1988
- Activity of five fluoroquinolones against mycobacterium avium-intracellulare complex and M. XenopiAnnales de l'Institut Pasteur / Microbiologie, 1988
- Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1986
- In-vitro susceptibility of mycobacteria to ciprofloxacinJournal of Antimicrobial Chemotherapy, 1985
- Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosisJournal of Clinical Microbiology, 1985
- THERAPEUTIC EFFECT OF A NEW ANTIBACTERIAL SUBSTANCE OFLOXACIN (DL8280) ON PULMONARY TUBERCULOSISPublished by Elsevier ,1985
- In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasiiAntimicrobial Agents and Chemotherapy, 1984